DRUG · Mapped RxNorm record
candesartan cilexetil
Normalized identity: candesartan cilexetilView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody
NCT00360763
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hypertensionunresolved
Interventions
candesartan cilexetilDRUG · verified · RxNorm: candesartan cilexetil
Sponsors & collaborators
Huazhong University of Science and Technologylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00360763 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.